Fang L - Search Results

1

Biodistribution of HuCC49DeltaCH2-beta-galactosidase in colorectal cancer xenograft model.

Yu Y, Fang L, Sun D. Yu Y, et al. Among authors: fang l. Int J Pharm. 2010 Feb 15;386(1-2):208-15. doi: 10.1016/j.ijpharm.2009.11.020. Epub 2009 Nov 26. Int J Pharm. 2010. PMID: 19944136 Free PMC article.

2

Synthesis and enzyme-specific activation of carbohydrate-geldanamycin conjugates with potent anticancer activity.

Cheng H, Cao X, Xian M, Fang L, Cai TB, Ji JJ, Tunac JB, Sun D, Wang PG. Cheng H, et al. Among authors: fang l. J Med Chem. 2005 Jan 27;48(2):645-52. doi: 10.1021/jm049693a. J Med Chem. 2005. PMID: 15658879

3

Syntheses and biological activities of rebeccamycin analogues with uncommon sugars.

Zhang G, Shen J, Cheng H, Zhu L, Fang L, Luo S, Muller MT, Lee GE, Wei L, Du Y, Sun D, Wang PG. Zhang G, et al. Among authors: fang l. J Med Chem. 2005 Apr 7;48(7):2600-11. doi: 10.1021/jm0493764. J Med Chem. 2005. PMID: 15801850

4

Syntheses and biological activities of disaccharide daunorubicins.

Zhang G, Fang L, Zhu L, Aimiuwu JE, Shen J, Cheng H, Muller MT, Lee GE, Sun D, Wang PG. Zhang G, et al. Among authors: fang l. J Med Chem. 2005 Aug 11;48(16):5269-78. doi: 10.1021/jm050144u. J Med Chem. 2005. PMID: 16078845

5

Syntheses and biological activity of bisdaunorubicins.

Zhang G, Fang L, Zhu L, Sun D, Wang PG. Zhang G, et al. Among authors: fang l. Bioorg Med Chem. 2006 Jan 15;14(2):426-34. doi: 10.1016/j.bmc.2005.08.014. Epub 2005 Sep 22. Bioorg Med Chem. 2006. PMID: 16182536

6

Discovery of a daunorubicin analogue that exhibits potent antitumor activity and overcomes P-gp-mediated drug resistance.

Fang L, Zhang G, Li C, Zheng X, Zhu L, Xiao JJ, Szakacs G, Nadas J, Chan KK, Wang PG, Sun D. Fang L, et al. J Med Chem. 2006 Feb 9;49(3):932-41. doi: 10.1021/jm050800q. J Med Chem. 2006. PMID: 16451059

7

Syntheses and biological activities of 3'-azido disaccharide analogues of daunorubicin against drug-resistant leukemia.

Zhang G, Fang L, Zhu L, Zhong Y, Wang PG, Sun D. Zhang G, et al. Among authors: fang l. J Med Chem. 2006 Mar 9;49(5):1792-9. doi: 10.1021/jm050916m. J Med Chem. 2006. PMID: 16509594

8

Why is it challenging to predict intestinal drug absorption and oral bioavailability in human using rat model.

Cao X, Gibbs ST, Fang L, Miller HA, Landowski CP, Shin HC, Lennernas H, Zhong Y, Amidon GL, Yu LX, Sun D. Cao X, et al. Among authors: fang l. Pharm Res. 2006 Aug;23(8):1675-86. doi: 10.1007/s11095-006-9041-2. Pharm Res. 2006. PMID: 16841194 Review.

9

Glucose uptake inhibitor sensitizes cancer cells to daunorubicin and overcomes drug resistance in hypoxia.

Cao X, Fang L, Gibbs S, Huang Y, Dai Z, Wen P, Zheng X, Sadee W, Sun D. Cao X, et al. Among authors: fang l. Cancer Chemother Pharmacol. 2007 Mar;59(4):495-505. doi: 10.1007/s00280-006-0291-9. Epub 2006 Aug 12. Cancer Chemother Pharmacol. 2007. PMID: 16906425

10

Enzyme specific activation of benzoquinone ansamycin prodrugs using HuCC49DeltaCH2-beta-galactosidase conjugates.

Fang L, Battisti RF, Cheng H, Reigan P, Xin Y, Shen J, Ross D, Chan KK, Martin EW Jr, Wang PG, Sun D. Fang L, et al. J Med Chem. 2006 Oct 19;49(21):6290-7. doi: 10.1021/jm060647f. J Med Chem. 2006. PMID: 17034135 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,974 results

Search Page

Filters